Menu

Genealogy Website Helped Crack Golden State Killer Case

DNA from a relative of the suspect submitted to the site GEDmatch gave investigators just enough information to identify him, but the process raises privacy concerns.

Apr 27, 2018
Ashley Yeager



ISTOCK, STEVANOVICIGOR An online DNA and genealogical database has helped investigators solve a decades-old cold case—the identity the “Golden State Killer,” who killed 12 people and raped 51 others between 1974 and 1986, The Sacramento Bee reported yesterday (April 26).

Investigators made a partial DNA match between an unidentified relative of Joseph James DeAngelo from a genealogy website and DNA taken from a crime scene linked with the case. The police then went to DeAngelo’s home and obtained a fresh DNA sample from something he discarded. The sample matched evidence from a series of past crimes, leading to DeAngelo’s arrest.

In the case, the lead investigator Paul Holes tells The Mercury News, his team used GEDmatch, a site based in Florida that collects publically shared genetic profiles of people. Users “upload raw genetic data in the form of endless A’s and C’s and G’s and T’s—a process that hypothetically could have allowed investigators to get the information they needed without getting cooperation from companies,” according to STAT. This appears to be one of the first instances where law enforcement has used genealogy data submitted to a public website to identify criminal suspects.

“I haven’t come across this before,” John Roman, a forensics expert who studied DNA use in criminal investigations and is now a senior fellow at the research organization NORC at the University of Chicago, tells The Bee. “If that’s how the match was obtained, then I would think there would be court battles to come.”

One issue may be the use of genetic data without permission from the company. According to a statement from GEDmatch operator Curtis Rogers quoted in The Mercury News, law enforcement did not let the company know it had used its data. But, Rodgers notes, “it has always been GEDmatch’s policy to inform users that the database could be used for other uses, as set forth in the Site Policy. . . . While the database was created for genealogical research, it is important that GEDmatch participants understand the possible uses of their DNA, including identification of relatives that have committed crimes or were victims of crimes.” Other companies, including 23andMe and Ancestry.com, are more protective of users’ information, only handing it over in order to comply with legal processes, according to STAT.

“I don’t want to be cavalier about privacy issues,” Robert Green, a medical geneticist and professor at Harvard Medical School, tells Buzzfeed. “But if this was a legally approved use of a public database, or a legally issued subpoena or warrant for a private database, and it successfully identified a horrible criminal, I think that’s a really exciting and creative use of genealogical data.”

Laura Hercher, a genetic counselor and director of student research at the Sarah Lawrence College graduate program in human genetics, tells Buzzfeed that the application of genealogy data to a crime case raises another concern—the potential for the data to be abused. “It’s the killer app for this technology—the literal killer app,” she says. “If people were using it to track immigrants, we’d be rightfully up in arms.”

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb

Marketplace

Sponsored Product Updates

WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
INTEGRA Biosciences is offering labs the chance to win a VIAFLO 96/384 pipette. Designed to simplify plate replication, plate reformatting or reservoir-to-plate transfers, the VIAFLO 96/384 allows labs without the space or budget for an expensive pipetting robot to increase the speed and throughput of routine tasks.
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
With this application note from Taconic, learn about the power that the CRISPR/Cas system has to revolutionize the field of custom mouse model generation!
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
This webinar, from Crown Bioscience, presents a unique continuum of translational dysmetabolic platforms that more closely mimic human disease. Learn about using next-generation rodent and spontaneously diabetic non-human primate models to accurately model human-relevant disease progression and complications related to obesity and diabetes here!